Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Radiofrequency Augmentation Techniques, part of the Atlas of Interventional Pain Management series, is a concise, practical guide that provides clinicians with detailed, step-by-step guidance on how to perform the latest interventional techniques for treating patients with chronic pain. This comprehensive, easy-to-follow guide offers expert coverage of how to deliver safe, accurate, and cost-effective pain relief to patients using all clinically useful imaging modalities, including ultrasound-guided techniques and fluoroscopy. With high-quality images and clear, authoritative guidance throughout, it shows exactly how to evaluate the causes of pain, identify the most promising stimulation technique, locate the site with precision, and deliver effective relief."--Provided by publisher.

Radiotherapy. --- Pain --- Radiofrequency Ablation --- Radiotherapy --- Radiothérapie. --- Douleur --- Pain --- Radiotherapy --- Treatment. --- methods --- Traitement. --- Treatment

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Since the 1990s, ultrasound (US) has played a major role in the assessment of thyroid nodules and their risk of malignancy. Over the last decade, the most eminent international societies have published US-based systems for the risk stratification of thyroid lesions, namely, Thyroid Imaging Reporting And Data Systems (TIRADSs). The introduction of TIRADSs into clinical practice has significantly increased the diagnostic power of US to a level approaching that of fine-needle aspiration cytology (FNAC). At present, we are probably approaching a new era in which US could be the primary tool to diagnose thyroid cancer. However, before using US in this new dominant role, we need further proof. This Special Issue, which includes reviews and original articles, aims to pave the way for the future in the field of thyroid US. Highly experienced thyroidologists focused on US are asked to contribute to achieve this goal.

Medicine --- Clinical & internal medicine --- n/a --- thyroid --- ultrasonography --- follicular neoplasm --- follicular lesion of unknown significance --- follicular thyroid cancer --- papillary thyroid carcinoma --- neoplasm metastasis --- biopsy --- fine-needle --- thyroglobulin --- US-guided minimally invasive techniques --- radiofrequency ablation --- RFA --- benign thyroid nodules --- thyroid cancer --- DTC recurrences --- PTMC --- long term --- follow-up --- regrowth --- classification system --- ultrasound classification system --- TIRAD --- nodule --- risk stratification --- TI-RADS --- fine-needle aspiration --- cancer --- ultrasound --- scintigraphy --- non-autonomously functioning --- thyroid imaging reporting and data systems (TIRADS) --- risk of malignancy (ROM) --- thyroid nodules --- paediatrics --- radiotherapy --- risk assessment --- DTC --- thyroid neoplasm --- medical imaging --- artificial intelligence --- machine learning --- deep learning --- radiomics --- prediction --- diagnosis --- Thyroid Imaging Reporting and Data Systems (TIRADS) --- pediatric thyroid nodules --- neck ultrasound --- contrast-enhanced ultrasound (CEUS) --- papillary thyroid cancer --- TIRADS --- thyroid nodule --- fine-needle aspiration biopsy --- elastosonography

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment.

polycythemia --- peptide receptor radiotherapy --- n/a --- vasculogenesis --- catecholamines --- neuroendocrine --- GTV --- adaptive immunity --- therapy resistance --- histology --- transgenic mice --- cryoablation --- spheroids --- energy metabolism --- somatostatinoma --- angiogenesis --- pheochromocytoma --- SDHD --- percutaneous ethanol injection --- metanephrines --- SDHB --- global longitudinal strain --- mutation --- normetanephrines --- catecholamine --- PASS --- PGL --- 177Lu-DOTATATE --- chromosomal alteration --- speckle-tracking echocardiography --- lL-6 --- dog --- percutaneous ablation --- stem-like tumor cells --- EPAS1 --- neural crest --- fluorescence imaging --- neutrophil --- xenograft --- inflammation --- head and neck --- weighted standard deviation --- FGF21 --- calorimetry --- HIF --- average real variability --- next-generation sequencing --- adrenocortical carcinoma --- carotid body --- hypoxia-inducible factor --- paraganglioma --- succinate dehydrogenase --- blood pressure variability --- arrhythmia --- mortality --- NF1 --- toll-like receptor --- GAPP --- NET --- subclinical systolic dysfunction --- pheochromocytoma and paraganglioma --- PET-CT --- pan-cancer analysis --- mouse pheochromocytoma cells --- innate immunity --- neurogenesis --- neuroendocrine tumor --- obesity --- hypotension --- hypoxia --- CNV detection --- 18F-FDOPA --- comparative genomics --- adrenomedullary function --- PCC --- pathogen-associated molecular patterns --- adrenal tumor --- radiotherapy --- 11C-hydroxy-ephedrine --- radiofrequency ablation --- PPGL --- minimally invasive procedure --- sporadic --- diabetes mellitus --- adrenal incidentaloma --- germline mutation --- immunotherapy --- VHL --- immunohistochemistry --- metastatic OR malignant pheochromocytoma --- erythropoietin --- postoperative --- targeted therapy --- PRRT --- metastatic --- mitochondria --- T cell --- TCA cycle --- meta-analysis --- pseudohypoxia --- ectopic secretion --- radiosensitization --- chromogranin A --- hereditary --- hypertension --- PET --- phosphorylation tyrosine hydroxylase